Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
Europe’s primary equity-linked market has reopened, with a new €125m convertible bond from Pharming Group, the Dutch speciality pharmaceuticals company. -
Sinopharm Holding (China) Finance Leasing Co is seeking a $215m-equivalent loan.
-
German pharmaceutical firm Vetter launched a Schuldschein on Tuesday, which is the first such offering in the market in 2020.
-
Hong Kong-listed MicroPort Scientific Corp is looking at spinning off and listing its heart treatment subsidiary, according to a stock exchange filing.
-
I-Mab, a China-based biopharmaceutical company, has kicked off the roadshow for its up to $111.1m Nasdaq IPO, more than two months after filing draft documents with the US regulator.
-
Credit Suisse has chosen a banker from Deutsche Bank to co-lead its healthcare team in Europe, the Middle East and Africa.
